Sgemaglutide in type 2 diabetes – is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)?

Sheila A. Doggrell
  • Expert Opinion on Drug Metabolism & Toxicology, February 2018, Taylor & Francis
  • DOI: 10.1080/17425255.2018.1441286

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/17425255.2018.1441286

In partnership with: